Mankind Pharma Limited — Others, 04-07-2025: Certificate under SEBI (Depositories and Participants) Regulations, 2018

Mankind Pharma has announced a board meeting to consider the financial results for the quarter and half-year. Separately, its registrar confirmed no requests for dematerialization or rematerialization of shares were received in the recent quarter, indicating stable shareholding activity. This suggests steady investor interest and administrative upkeep without structural changes in shareholding.